Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Nov / Leading in an Era of Personalized Medicine
Technology and innovation Bioinformatics Opinion and Personal Narratives

Leading in an Era of Personalized Medicine

Pathology labs are ideally positioned to drive patient-centric care

By E. Blair Holladay 11/01/2024 Opinion 3 min read

Share

Personalized medicine is playing an increasingly important role in healthcare, presenting a great opportunity for pathologists and medical laboratory scientists to solidify their role as foundational leaders.

Our collective responsibility is to provide high-quality patient care for all – and to ensure that each test and each diagnosis fulfills our mission of providing patient-centered care. We play a crucial role of delivering precise, patient-specific data that personalized medicine would be nothing without. As the era of personalized medicine expands, pathologists and medical laboratory scientists are ideally positioned to lead the way – and to usher in a new standard of patient care.

The data we provide is what drives individualized treatment decisions. We are the ones delivering the results and information from genetic testing, molecular diagnostics, or biomarker identification. These data directly inform courses of action and treatment. We all know that no two patients – or their genetic signatures – are alike, and that’s why, by better understanding each person’s unique biological characteristics, we can point them towards the most effective therapies, which ultimately helps improve their outcomes.

In short, data is everything in personalized medicine – and the medical laboratory is the collector and the keeper of that data. Our ability to test and discover can profoundly affect clinical decisions. Our ability and expertise to collect and interpret this data is what makes the laboratory indispensable.

Leading with AI
 

As precision medicine continues to evolve, the avalanche of data generated grows. To efficiently use this data to provide personalized care for our patients, we must embrace artificial intelligence (AI).

We know AI is not a catch-all solution; it cannot replace the complex and critical thinking needed in pathology and laboratory medicine. But what it can do is analyze data more quickly, providing the laboratory with information in a timelier fashion than we might otherwise achieve. What does that mean in practice? We can accelerate discovery, optimize tests, and do so much more to improve patient care and outcomes. 

To embrace AI is to embrace actionable insights for our patients and to solidify our leadership in personalized medicine.

A challenging road ahead
 

Navigating this burgeoning era of medicine is not without its challenges. Technology can be difficult to access due to budgetary constraints or lack of reimbursement. AI brings regulatory issues to contend with, and comes with a massive educational need and a great deal of training to organize. Yet the opportunities opening up for laboratories far outweigh the challenges. When we embrace innovation and when we challenge ourselves to expand upon our expertise, we create space to showcase our role as essential partners in healthcare and elevate our tenet of patient-centric care for all.

As healthcare rapidly shifts toward precision medicine, we are uniquely positioned to provide the insights and expertise needed to provide high-quality care. We are not just contributors; we are the drivers of this change and will help shape what care looks like for each and every patient.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

E. Blair Holladay

CEO of the American Society for Clinical Pathology

More Articles by E. Blair Holladay

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.